Sign In
Buy OTIC
$0.0085
+0 (+0%)
At Close: Jul 11, 2023
The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
12:24pm, Tuesday, 24'th Dec 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 23) 10X Genomics Inc (NASDAQ: TXG )(reacted to a rulin
Otonomy to Participate in Two Upcoming Investor Conferences
12:00am, Tuesday, 26'th Nov 2019Otonomy, Inc. 2019 Q3 - Results - Earnings Call Presentation
12:00am, Thursday, 07'th Nov 2019Otonomy Q3 EPS $(0.33) Beats $(0.45) Estimate, Sales $125K Miss $210K Estimate
12:00am, Tuesday, 05'th Nov 2019Analysts Estimate Otonomy (OTIC) to Report a Decline in Earnings: What to Look Out for
12:00am, Monday, 28'th Oct 2019AGTC And Otonomy Announce Strategic Collaboration To Develop And Commercialize Gene Therapy For Congenital Hearing Loss
12:00am, Tuesday, 01'st Oct 2019Otonomy to Present at the Cantor Global Healthcare Conference
12:00am, Thursday, 26'th Sep 2019Otonomy Reports Initiation Of Phase 1/2 Trial Of OTO-413 In Hearing Loss
12:00am, Tuesday, 17'th Sep 2019H.C. Wainwright Initiates Coverage On Otonomy with Buy Rating, Announces $8 Price Target
12:00am, Thursday, 29'th Aug 2019Otonomy's (OTIC) CEO David Weber on Q2 2019 Results - Earnings Call Transcript
12:00am, Friday, 02'nd Aug 2019Otonomy Filing Shows Registration For $40M Common Stock Offering
12:00am, Thursday, 01'st Aug 2019Acoustic Language Processing is the poster child for Industry 4.0
03:00pm, Wednesday, 08'th May 2019
ALP isn’t just applicable to customer service — it can also power the next generation of speech technology and meet a massive need across industries.
